GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Clinical trials for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stomach cancer chemo study halted early after enrolling only 3 patients
Disease control TerminatedThis study compared two ways of giving FLOT chemotherapy to people with stomach or gastroesophageal junction cancer. One group received all four cycles before surgery, while the other had two cycles before and two after surgery. The study was stopped early after enrolling only 3 …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 16, 2026 23:50 UTC
-
Cancer drug trial halted early: PRT7732 studied for rare gene mutation
Disease control TerminatedThis early-stage study tested an experimental oral drug called PRT7732 in people with advanced solid tumors (like lung or stomach cancer) that have a specific genetic change called SMARCA4. The main goals were to check safety, find the right dose, and see if the drug shrinks tumo…
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Experimental stomach cancer combo trial halted after only 2 patients
Disease control TerminatedThis early-stage study tested a new drug called AUR103 combined with standard treatments (trastuzumab and chemotherapy) for people with advanced HER2-positive stomach or gastroesophageal junction cancer. The goal was to see if the combination was safe and effective. However, the …
Matched conditions: GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Aurigene Discovery Technologies Limited • Aim: Disease control
Last updated May 13, 2026 16:01 UTC